Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
Send biological product deviation report via email, link, or fax. You can also download it, export it or print it out.
How to use or fill out Form FDA 3486 Biological Product Deviation Report with our platform
Ease of Setup
DocHub User Ratings on G2
Ease of Use
DocHub User Ratings on G2
Click ‘Get Form’ to open the Form FDA 3486 in the editor.
Begin by filling out the 'Product Information' section. Enter the product name, lot number, and expiration date as required.
Next, move to the 'Deviation Description' field. Provide a detailed account of the deviation, including dates and any relevant circumstances.
In the 'Corrective Actions' section, outline any actions taken to address the deviation. Be specific about measures implemented to prevent recurrence.
Finally, complete the 'Submitter Information' section with your name, title, and contact details. Ensure all fields are accurately filled before submission.
Start using our platform today for free to streamline your form completion process!
Fill out Form FDA 3486 FDA 3486 Biological Product Deviation Report online It's free
See more Form FDA 3486 FDA 3486 Biological Product Deviation Report versions
We've got more versions of the Form FDA 3486 FDA 3486 Biological Product Deviation Report form. Select the right Form FDA 3486 FDA 3486 Biological Product Deviation Report version from the list and start editing it straight away!
EMA definition A biological medicinal product is a medicinal product whose active substance is made by or derived from a living organism.
How does the FDA define a deviation?
In the FDAs guidance on quality management systems for the pharmaceutical industry and current Good Manufacturing Practice (cGMP) regulations, a deviation is described as a result that falls outside the expected range or fails to fulfill a specific requirement.
What is a Bpdr in FDA?
biological product license and had control over the product when a deviation or unexpected event associated with manufacturing occurred, is required to submit a Biological Product Deviation Reports (BPDR) to FDA as soon as possible, but not later than 45 calendar days from the date of discovery of information that
What is a biological product deviation?
Biological product deviation (BPD) refers to unexpected events in manufacture, storage or distribution that deviate from the standard operating procedure. BPD reporting is mandated by the FDA and governed by title 21 of the Code of Federal Regulations (CFR)
How do I submit a BPDr to the FDA?
Reports should be submitted to CDER-BPDR@fda.hhs.gov using Form FDA 3486. To facilitate prompt processing of all incoming BPDRs, CDER strongly recommends that all information relevant to the BPDR be submitted in the Form FDA 3486.
form fda 3486
Form fda 3486 fda 3486 biological product deviation report quiBiological product deviation report guidanceDeviation guidelines FDA PDFFDA deviation guidanceFDA deviation definitionFDA BPD meetingFDA biological productBpdr mental health
Security and compliance
At DocHub, your data security is our priority. We follow HIPAA, SOC2, GDPR, and other standards, so you can work on your documents with confidence.
Biological products are a diverse category of products and are generally large, complex molecules. These products may be produced through biotechnology in a living system, such as a microorganism, plant cell, or animal cell, and are often more difficult to characterize than small molecule drugs.
What is an example of a biological product?
There are many types of biological products approved for use in the United States, including therapeutic proteins (such as filgrastim), monoclonal antibodies (such as adalimumab), and vaccines (such as those for influenza and tetanus).
Related links
Our STN: BL 125678/0
Sep 24, 2019 You must submit reports of biological product deviations submit a report on Form FDA 3486 to the Director, Office of Compliance and Biologics.
21 CFR 600.14 - Reporting of biological product deviations
(1) For biological products regulated by the Center for Biologics Evaluation and Research (CBER), send the completed Form FDA 3486 to the CBER Document
Cookie consent notice
This site uses cookies to enhance site navigation and personalize your experience.
By using this site you agree to our use of cookies as described in our Privacy Notice.
You can modify your selections by visiting our Cookie and Advertising Notice.
